Dr. Brendan LeeRESEARCH

Fresolimumab – a potential therapy for OI

04/08/2021By

In OIFE Magazine 2-2021 we published an interview with Brendan Lee, M.D. Ph.D., Baylor College of Medicine, Houston, Texas about research on the potential therapy Fresolimumab (TGFb). Who are you and what is your relationship to OI? I am a pediatrician and clinical geneticist who has engaged in basic, translational, and clinical research in skeletal…

READ MORE
Collage clinical imagesRESEARCH

Investigating Denosumab in children with OI

17/11/2020By

Clinical trial: Investigating Denosumab in children with OI Interview with Dr. Jörg Oliver Semler, Paediatrician, OIFE Medical Advisory Board (MAB) How did the project of investigating denosumab in children start? Regarding the use of denosumab in OI there are a few projects which have to be separated. At the beginning there were a few case…

READ MORE
Translate »